Diagnostic significance of the human papilloma virus detection in blood
https://doi.org/10.25789/YMJ.2018.64.30
Abstract
There is still no clear understanding of the human papillomavirus infecting, as well as its eliminating process from the body. It is known that cervical cancer is caused by human papillomavirus in 99 percent of cases, but only in a small number of human papillomavirus infected women leads to develop cervical cancer. At the same time, based on cytological and histological analysis of the women cervical samples, it is currently impossible to establish criteria that would indicate the malignant progression possibility. Blood, as a unique tissue with specific and nonspecific protective adaptive mechanisms, can be a source of crucial information about the human body papillomavirus infecting. The article provides an overview of the research devoted to the human papillomavirus detection in blood and identifies unresolved issues arising from these studies.
About the Authors
I. V. KononovaRussian Federation
Kononova Irina Vasilyevna – Candidate of Medical Sciences, the Research Worker of YSC CMP Department of epidemiology of chronic non-communicable diseases Laboratory of Precancerogenesis and Malignant Tumors
677000, Yakutsk, Sergelyakhskoye shosse, 4
F. A. Zakharova
Russian Federation
Zakharova Fedora Apollonovna – Doctor of Medical Sciences, Professor of North-Eastern Federal University named after M. K. Ammosov Medical Institute Department of Normal and Pathological Physiology
677000, Yakutsk, ulitsa Belinskogo, 58
M. P. Kirillina
Russian Federation
Kirillina Marya Petrovna – Candidate of Biological Sciences, the Leading Research Worker – the Head of YSC CMP Department of epidemiology of chronic non-communicable diseases Laboratory of Precancerogenesis and Malignant Tumors; the Head of North Eastern Federal University named after M. K. Ammosov Medical Institute Pathomorphology, Histology and Cytology Educational and Scientific Laboratory
677000, Yakutsk, Sergelyakhskoye shosse, 4
Yakutsk, ulitsa Belinskogo, 58
P. V. Nikiforov
Russian Federation
Nikiforov Petr Vladimirovich – Doctor of Medicine, Oncologist, Surgeon of GBU Yakut Republican Oncology Center General Surgery Department
677000, Yakutsk, ulitsa Sverdlova, 3, k.2
S. N. Mamaeva
Russian Federation
Mamaeva Sargylana Nikolaevna - Candidate of Physical and Mathematical Sciences, the Associate Professor of North-Eastern Federal University named after M. K. Ammosov Physics and Technology Institute Department of General and Experimental Physics
677000, Yakutsk, ulitsa Belinskogo, 58
S. R. Antonov
Russian Federation
Antonov Stepan Romanovich – Candidate of Physical and Mathematical sciences, the Associate Professor of North-Eastern Federal University named after M. K. Ammosov Physics and Technology Institute Department of Radio Physics and Electronics
677000, Yakutsk, ulitsa Belinskogo, 58
A. N. Pavlov
Russian Federation
Pavlov Aleksandr Nikolaevich – the Head of North-Eastern Federal University named after M. K. Ammosov Physics and Technology Institute Department of Radio Physics and Electronics Laboratory
677000, Yakutsk, ulitsa Belinskogo, 58
N. A. Nikolaeva
Russian Federation
Nikolaeva Nadezhda Anatolyevna – the Assistant of North-Eastern Federal University named after M. K. Ammosov Physics and Technology Institute Department of General and Experimental Physics
677000, Yakutsk, ulitsa Belinskogo, 58
References
1. Arias Y. Human papillomavirus (HPV) detected in restored plasma DNA from women diagnosed with pre-invasive lesions and invasive cervical cancer / Y.Arias, E.Carrillo, F. Aristizabal // Colombia Médica. - 2010. – Vol. 41. – Issue 2. – P. 148-154. – URL: http://colombiamedica.univalle.edu.co/index.php/comedica/article/ view/696/794 Дата обращения: 18 сентября 2018.
2. Can recurrence of cervical cancer be predicted by human papillomavirus DNA in nodes or plasma? / A. Peedicayil [et al.] // Journal of Low Genital Tract Disease. – 2009. – Vol. 13. – Issue 2. P. 102-106. - doi: 10.1097/LGT.0b013e31818c66e6.
3. Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma / Jeannot E. [et al.] // The Journal of Pathology: Clinical Research. - 2016. – Vol. 2. - Issue 4. – P. 201-209. – doi: https://doi.org/10.1002/cjp2.47
4. Could human papillomaviruses be spread through blood? / Bodaghi S. [et al.] // Journal of Clinical Microbiology. - 2005. – Vol.43. – Issue 11. – P. 5428–5434. http://doi.org/10.1128/JCM.43.11.5428-5434.2005
5. Detection and Analysis of Human Papillomavirus (HPV) DNA in Breast Cancer Patients by an Effective Method of HPV Capture / Wang T. [et al.] // PLoS ONE: 2014. – Vol. 9. – Issue 3. - e90343. – doi: https://doi.org/10.1371/journal.pone.0090343
6. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma / Capone R.B. [et al.] // Clinical Cancer Research. - 2000. – Vol. 6. – Issue 11. – P. 4171-4175.
7. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma / Dong S.M. [et al.] // Cancer Epidemiology, Biomarkers & Prevention. - 2002. – Vol. 11. – Issue 1. – P. 3-6.
8. Detection and Quantitation of Human Papillomavirus DNA in the Plasma of Patients with Cervical Carcinoma / S.M. Dong [et al.] // Cancer Epidemiology, Biomarkers & Prevention. - 2002. – Vol. 11. – Issue 1. – P. 3-6.
9. Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer / Kay P. [et al.] // Journal of Medical Virology. - 2005. – Vol. 75. – Issue 3. – P. 435-439 – doi: https://doi.org/10.1002/jmv.20294
10. Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis / C.J. Tseng [et al.] // Journal of Clinical Oncology. - 1999. – Vol. 17. – Issue 5. – P. 1391- 1396.
11. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history / A. [et al.] Widschwendter // Journal of Clinical Virology. - 2004. – Vol. 31. – Issue 4. – P. 292-297. – doi: https://doi.org/10.1016/j.jcv.2004.06.009
12. Drennan M. What is ‘Sterile Blood’? / M. Drennan // British Medical Journal. – 1942. - Vol.2. – P. 526. - doi: https://doi.org/10.1136/bmj.2.4269.526
13. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups / C.K. Ong [et al.] // Journal of Virology. - 1993. – Vol. 67. – Issue 11. – P. 6424- 6431.
14. HPV DNA in plasma of patients with cervical carcinoma / N. Sathish [et al.] // Journal of Clinical Virology. – 2004. – Vol. 31. – Issue 3. – P. 204-209. – doi: https://doi.org/10.1016/j.jcv.2004.03.013
15. Human papillomavirus DNA detected in peripheral blood samples from healthy Australian male blood donors / A.C. Chen [et al.] // Journal of Medical Virology. - 2009. – Vol. 81. – Issue 10. – P. 1792-1796. – doi: https://doi.org/10.1002/jmv.21592
16. Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia / C.E. Cocuzza [et al.] // PLoS ONE. - 2017. – Vol. 12. – Issue 11. - e0188592. – doi: https://doi.org/10.1371/journal.pone.0188592
17. Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia / C.E. Cocuzza [et al.] // PLoS ONE. – 2017. – Vol. 12. – Issue 11. - e0188592. - doi:10.1371/journal.pone.0188592
18. Human papillomavirus DNA in plasma of patients with cervical cancer / W. Pornthanakasem [et al.] // BMC Cancer. – 2001. – Vol. 1:2. – doi: http://doi.org/10.1186/1471-2407-1-2
19. Human papillomavirus DNA in sera of cervical cancer patients as tumor marker / A. Widschwendter [et al.] // Cancer Letter. – 2003. – Vol.202. – Issue 2. – P. 231–239. – doi: https://doi.org/10.1016/j.canlet.2003.09.006
20. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide / J. M. Walboomers [et al.] // The Journal of Pathology. – 1999. - Vol. 189. – Issue 1. – P. 12-19. – doi: https://doi.org/10.1002/ (SICI)1096-9896(199909)189:1<12::AIDPATH431>3.0.CO;2-F
21. Human papillomavirus proteins are found in peripheral blood and semen Cd20+ and Cd56+ cells during Hpv-16 semen infection / C. Foresta [et al.] // BMC Infectious Diseases. - 2013. – Vol. 13:593. - https://doi.org/10.1186/1471-2334-13-593
22. Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells / C.C. Pao [et al.] // American Journal of Clinical Pathology. - 1991. – Vol. 95. – Issue 4. – P. 540-546.
23. Longworth M. S. Pathogenesis of Human Papillomaviruses in Differentiating Epithelia // M.S. Longworth, L.A. Laimins // Microbiology and Molecular Biology Reviews. – 2004. – Vol. 68. – Issue 2. – P. 362–372. – doi: http://doi.org/10.1128/MMBR.68.2.362-372.2004
24. Longworth M.S. The Binding of Histone Deacetylases and the Integrity of Zinc Finger-Like Motifs of the E7 Protein Are Essential for the Life Cycle of Human Papillomavirus Type 31 // M.S. Longworth, L.A. Laimins // Journal of Virology. – 2004. – Vol. 78. – Issue 7. – P. 3533-3541. - doi: 10.1128/JVI.78.7.3533-3541.2004
25. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients / Liu V.W. [et al.] // Gynecologic Oncology. - 2001. – Vol. 82. – Issue 2. – P. 269-272.
26. Lowy D.R. Reducing HPV-Associated Cancer Globally / D.R. Lowy, J. T. Schiller // Cancer Prevention Research. – 2012. – Vol. 5. - Issue 1. – P. 18-23. - doi: 10.1158/1940-6207. CAPR-11-0542
27. Sasagawa T. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer // T. Sasagawa, H. Takagi, S. Makinoda // Journal of Infection and Chemotherapy. - 2012. – Vol.18. – Issue 6. – P. 807-815. – doi: https://doi.org/10.1007/s10156-012-0485-5
28. Stanley M.A. Epithelial Cell Responses to Infection with Human Papillomavirus / M.A. Stanley // Clinical Microbiology Reviews. – 2012. – Vol. 25. – Issue 2. – P. 215–222. – doi: http://doi.org/10.1128/CMR.05028-11
29. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan / H.-L. Chiou [et al.] // Cancer. - 2003. – Vol. 97. – Issue 6. – P. 1558–1563. – doi: https:// doi.org/10.1002/cncr.11191
30. Transplacental transmission of Human Papillomavirus / R.L. Rombaldi [et al.] // Virology Journal. - 2008. – Vol. 5:106. – doi: https://doi.org/10.1186/1743-422X-5-106
31. Woodman C.B.J. The natural history of cervical HPV infection: unresolved issues / C.B.J. Woodman, S. I. Collins, L.S. Young // Nature Reviews Cancer. – 2007. – Vol. 7. – P. 11–22.
Review
For citations:
Kononova I.V., Zakharova F.A., Kirillina M.P., Nikiforov P.V., Mamaeva S.N., Antonov S.R., Pavlov A.N., Nikolaeva N.A. Diagnostic significance of the human papilloma virus detection in blood. Yakut Medical Journal. 2018;(4):100-101. https://doi.org/10.25789/YMJ.2018.64.30